|
|
Nigeria
|
Cervarix Vaccine
|
Human papillomavirus bivalent (types 16 & 18) L1 protein vaccine, recombinant
|
Vaccines and Biologics
|
Intramuscular
|
Registered
|
Details →
|
|
|
Nigeria
|
GARDASIL Suspension for Intramuscular Injection
|
Human papillomavirus quadrivalent (types 6, 11, 16, & 18) L1 protein vaccine, recombinant
|
Vaccines and Biologics
|
Intramuscular
|
Registered
|
Details →
|
|
|
Zimbabwe
|
2025/18.2/6989
|
GARDASIL
|
HUMAN PAPILLOMAVIRUS (HPV)
|
MERCK SHARP & DOHME LLC, 770 SUMNEYTOWN PIKE, PENNSYLVANIA, .., U.S.A.;
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
Details →
|
|
|
Zimbabwe
|
2025/18.2/7028
|
GARDASIL 9
|
HUMAN PAPILLOMAVIRUS (HPV)
|
MERCK & CO INC, NEW JERSEY, 126 EAST LINCOLN AVENUE, NEW JERSEY, RAHWAY, USA;
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
Details →
|
|
|
Kenya
|
H2025/CTD12769/26449
|
GARDASIL 9
|
HUMAN PAPILLOMAVIRUS (HPV) 9-VALENT VACCINE
|
IMPERIAL MANAGED SOLUTIONS EAST AFRICA LTD- MLOLONGO
|
Registered
|
Details →
|
|
|
Kenya
|
H2025/CTD12746/26444
|
GARDASIL 9
|
HUMAN PAPILLOMAVIRUS (HPV) 9-VALENT VACCINE
|
IMPERIAL MANAGED SOLUTIONS EAST AFRICA LTD- MLOLONGO
|
Registered
|
Details →
|
|
|
Uganda
|
NDA/MAL/HDP/1675
|
QUADRIVALENT HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE (TYPES 6, 11, 16, 18)
|
-
|
MERK & CO. INC, SUMNEYTOWN PIKE, P.O BOX 4, WEST POINT, PENNSYLVANIA, U.S. 19486, USA
|
Registered
|
Details →
|
|
|
Kenya
|
18274
|
GARDASIL
|
QUADRIVALENT HUMAN PAPILLOMAVIRUS (TYPES 6,11, 16, 18) RECOMBINANT VACCINE
|
IMPERIAL MANAGED SOLUTIONS EAST AFRICA LTD- MLOLONGO
|
Registered
|
Details →
|
|
|
Tanzania
|
TAN 09,180 J07A MSD
|
Gardasil
|
Human Papillomavirus type 11 L1 Protein 40 mcg/0.5ml,Human Papillomavirus type 16 L1 Protein 40 mcg/0.5ml,Human Papillomavirus type 18 L1 Protein 20 mcg/0.5ml,Human Papillomavirus type 6 L1 Protein 20 mcg/0.5ml,L-Histidine 0.78 ml/100ml,Polysorbate 80 50 mcg/ml,Sodium Borate 35 mcg/ml,Sodium Chloride 9.56 ml/100ml
|
Merck Sharp & Dohme Corp.
|
Registered/Compliant
|
Details →
|
|
|
Zambia
|
ZAMRA-HM-25-153
|
Gardasil™ 9 Pre-Filled Syringe
|
Human Papillomavirus (HPV) 9-valent vaccine
|
Merck Sharp & Dohme LLC
|
Registered/Compliant
|
Details →
|
|
|
Ghana
|
FDA/HVC/265-06006
|
GARDASIL SUSPENSION FOR INJECTION,HUMAN PAPILLOMAVIRUS,RECOMBINANT ADSORBED VACCINE(TYPES 6,11,16,18)
|
HUMAN PAPILLOMAVIRUS
|
MERCK SHARP&DOHME BV.WAARDEWEG 39 HAARLEM 2031BN.NETHERLANDS
|
Valid
|
Details →
|
|
|
Ghana
|
FDA/HVC/255-04009
|
GARDASIL 9 0.5ML/DOSE SUSPESION (HUMAN PAPILLOMAVIRUS 9-VALENT) VACCINE RECOMBINANT (VIAL)
|
HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE RECOMBINANT
|
MERCK SHARP & DOHME LLC 770 SUNNEY TOWN PIKE, WEST POINT PENNSYLVANIA19486; MDS INTERNATIONAL GmbH T/A MDS IRELAND (CARLOW) DUBLIN ROAD, CARLOW CO.; MERCK SHARP & DOHME B.V WAARDERWEG 39 HAARLEM 2031 BN THE NETHERLANDS
|
Valid
|
Details →
|
|
|
Ghana
|
FDA/HVC/255-04008
|
GARDASIL 9 0.5ML/DOSE SUSPESION (HUMAN PAPILLOMAVIRUS 9-VALENT) VACCINE RECOMBINANT (PRE-FILLED SYRINGE)
|
HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE RECOMBINANT
|
MERCK SHARP & DOHME LLC 770 SUNNEY TOWN PIKE, WEST POINT PENNSYLVANIA19486; MDS INTERNATIONAL GmbH T/A MDS IRELAND (CARLOW) DUBLIN ROAD, CARLOW CO.; MERCK SHARP & DOHME B.V WAARDERWEG 39 HAARLEM 2031 BN THE NETHERLANDS
|
Valid
|
Details →
|
|
|
Zambia
|
ZAMRA-HM-25-151
|
Gardasil™ 9 suspension for injection, Vial
|
Human Papillomavirus (HPV) 9-valent vaccine
|
Merck Sharp & Dohme LLC
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TAN 08,160 J07A GSK
|
Cervarix Vaccine
|
3 - O - deacyl- 4- monophosphoryl lipid A 50 mcg/ml,Aluminium Hydroxide 0.5 mg,Human Papillomavirus type 16 L1 Protein 20 µg/0.5 ml,Human Papillomavirus type 18 L1 Protein 20 µg/0.5 ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TAN 22 V 0513
|
Gardasil
|
Aluminium hydroxy-phosphate sulfate 225 mcg/ml,Human Papillomavirus type 11 L1 Protein 40 mcg/0.5ml,Human Papillomavirus type 16 L1 Protein 20 mcg/0.5ml,Human Papillomavirus type 18 L1 Protein 20 mcg/0.5ml,Human Papillomavirus type 6 L1 Protein 20 mcg/0.5ml,L-Histidine 0.78 ml/100ml,Polysorbate-80 50 mcg/ml,Sodium Borate 35 mcg/ml,Sodium Chloride 225 mcg/ml,Water for injections qs
|
Baxter Pharmaceutical Solutions LLC
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TAN 09,288 J07A MSD
|
Gardasil
|
Aluminium hydroxy-phosphate sulfate 225 mcg/ml,Human Papillomavirus type 11 L1 Protein 40 mcg/0.5ml,Human Papillomavirus type 16 L1 Protein 40 mcg/0.5ml,Human Papillomavirus type 18 L1 Protein 20 mcg/0.5ml,Human Papillomavirus type 6 L1 Protein 20 mcg/0.5ml,L-Histidine 0.78 ml/100ml,Polysorbate 80 50 mcg/ml,Sodium Borate 35 mcg/ml,Sodium Chloride 9.56 ml/100ml
|
Merck Sharp & Dohme Corp.
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TAN 26 V 0366
|
WALRINVAX
|
Aluminium Phosphate 225 mcg/0.5ml,Histidine 0.7725 mg/0.5ml,Human Papillomavirus type 16 L1 Protein 40 mcg/0.5ml,Human Papillomavirus type 18 L1 Protein 20 mcg/0.5ml,Polysorbate 80 0.025 mg/0.5ml,Sodium Chloride. 9.35 mg/0.5ml,Water for Injection qs QS
|
Yuxi Zerun Biotechnology Co., Ltd
|
Registered/Compliant
|
Details →
|